Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06319911 · ClinicalTrials.gov registry record
AETOS Shoulder System
A clinical trial of Shoulder Osteoarthritis and Shoulder Arthritis, sponsored by Smith & Nephew.
- Recruiting
- Registry status
- 220
- Enrollment target
- 5
- Study locations
NCT06319911: Recruiting study of Shoulder Osteoarthritis and Shoulder Arthritis, sponsored by Smith & Nephew.
NCT06319911 is a study of Shoulder Osteoarthritis and Shoulder Arthritis that is actively recruiting participants, run by Smith & Nephew. The registered enrollment target is 220 participants, above the 181-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (22% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06319911, a study of Shoulder Osteoarthritis and Shoulder Arthritis, is actively recruiting participants, sponsored by Smith & Nephew.
- RECRUITING
- Registry status
- 220 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study comparator group will be included, and there will be no randomization
Primary Outcome
Implant survivorship at 2 years post operatively defined as absence of device removal or revision of any component
Conditions Studied
Interventions
- DEVICE AETOS
Study Locations (5)
California
- California Pacific Orthopedics - San Francisco
Colorado
- Western Orthopaedics - Denver
Georgia
- Hughston Foundation - Columbus
Oregon
- Center for Orthopedics and Neurosurgical Care - Bend
Pennsylvania
- Rothman Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2024-03-05 |
| Est. Completion | 2030-08-30 |
What NCT06319911 shows while recruiting
NCT06319911 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, above the 181-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (22% higher).
The record links to 2 conditions, with Shoulder Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which AETOS is the first listed.
NCT06319911 lists 5 locations in 5 states (California, Colorado, Georgia).
Frequently Asked Questions
What is clinical trial NCT06319911 about?
NCT06319911 is a clinical study titled "AETOS Shoulder System". The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study ...
What is the current status of trial NCT06319911?
This trial is currently recruiting. The enrollment target is 220 participants. The study started on 2024-03-05. Estimated completion is 2030-08-30.
What conditions does trial NCT06319911 study?
This clinical trial studies the following conditions: Shoulder Osteoarthritis, Shoulder Arthritis.
What interventions are being tested in trial NCT06319911?
The interventions under investigation include: AETOS (DEVICE).
Who is sponsoring clinical trial NCT06319911?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06319911 being conducted?
This trial has 5 study locations across California, Colorado, Georgia, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06319911's enrollment target sits among peer trials
220 3rd of 9 higher than 7 of 9 other Shoulder Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rehabilitation Following Reverse Total Shoulder Arthroplasty
RECRUITING · NA
-
PRP for Glenohumeral Osteoarthritis
RECRUITING · Phase 4
-
CBD for Pain Following Orthopedic Shoulder Surgery
RECRUITING · Phase 1
-
Return to Golf After Orthopaedic Surgery
RECRUITING
-
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
RECRUITING · Phase 4
-
Zimmer Biomet Shoulder Arthroplasty PMCF
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI